News
The bill to the Kremlin reaches as much as 2 billion rubles a day in incentives to recruit the 30,000 military volunteers it ...
New Analyses of PSC Data from Phase 2 SPRING Trial Show that Treatment with Nebokitug Is Associated with Dose-Dependent and Significant Improvements in Multiple Inflammatory and Fibrotic Biomarkers Fu ...
The validation study, along with five additional abstracts ... reinforcing its potential to guide therapy selection and expand access to precision oncology. The poster, "Analytical validation of ...
2d
Miami's Community Newspapers on MSNDoing it all at FIU: One student’s experienceMeet a go-getter reaching well beyond the classroom and his chosen course of study to capitalize on diverse experiences. He ...
AP Biosciences doses first patient in phase 1 clinical study to evaluate AP402 for HER2+ cancer patients: Taipei City, Taiwan Thursday, April 24, 2025, 18:00 Hrs [IST] AP Bioscien ...
Indian Muslims today, unlike in the 1990s and 2000s, are firmly integrated with global Islamic issues, trends, and forces. In ...
The news got lost over draft weekend, but Penn State did finally land a proven receiver: Syracuse’s Trebor Pena, aka the guy ...
One of the best-known idioms in China is “women hold up half the sky”, a political slogan dating back to the late 1950s aimed at spurring women to break free from thousands of years of feudalist ...
Amylyx Pharmaceuticals, Inc. ("Amylyx" or the "Company") today announced that the first participant has been dosed in the pivotal Phase 3 LUCIDITY clinical trial of avexitide, an investigational, ...
Activity in preclinical models of ovarian, prostate, and non-small cell lung cancer supports potential utility of OP-3136, a KAT6 inhibitor, in indications beyond breast cancerPatient recruitment ...
“—blues. Oh, no I might need this one. Can I check out a book?” ...
ZW171 is a mesothelin (MSLN)-targeting TCE currently in a global Phase 1 clinical study (NCT06523803 ... Additionally, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results